Cycle de vie & signaux d'insolvabilité
0 événements du Moniteur belge
Aucun signal d'insolvabilité au Moniteur belge
Moniteur belge — actes
11 actes Évolution du capital · 3
12-02-2025
Modification du capital
01-07-2024
Modification du capital
03-01-2023
Modification du capital
Évolution de l'adresse · 1
20-09-2023
Changement de siège
Tous les actes · 11
mis à jour il y a 1 an
2025
17-06-2025 Publication au Moniteur belge — Divers
Résumé:
otherNotaire:
Peter VAN MELKEBEKE · BrusselÉtude:
BERQUIN NOTARISSEN
Détails techniques
{
"stage": null,
"notary": {
"name": "Peter VAN MELKEBEKE",
"firm_city": null,
"firm_name": "BERQUIN NOTARISSEN",
"office_city": "Brussel",
"is_associated": true
},
"act_meta": {
"language": "nl",
"pub_date": "2025-06-17",
"filing_date": "2025-06-13",
"act_kind_objet": "ONTSLAGEN, BENOEMINGEN, DIVERSEN"
},
"decision": {
"body": "buitengewone_algemene_vergadering",
"act_date": "2025-06-02",
"unanimous": null
},
"conversion": null,
"detected_kind": "other",
"report_waiver": null,
"restructuring": {
"parties": [
{
"kbo": "0722.705.230",
"name": "AUGUSTINE THERAPEUTICS",
"role": "other",
"address": "Gaston Geenslaan 3, 3001 Leuven",
"is_foreign": false,
"legal_form": "Naamloze vennootschap",
"is_new_company": false,
"jurisdiction_country": null
}
],
"exchange_ratio": null,
"legal_articles": [],
"is_cross_border": false,
"is_silent_merger": false,
"balance_basis_date": "2024-12-31",
"exchange_ratio_text": null,
"new_shares_issued_n": null,
"real_estate_included": false,
"patrimony_description": null,
"equity_transferred_eur": null,
"accounting_effective_date": null
},
"subject_company": {
"kbo": "0722.705.230",
"name_full": "AUGUSTINE THERAPEUTICS",
"legal_form": "Naamloze vennootschap"
},
"publication_proxy": {
"kind": "person",
"org_kbo": null,
"org_name": null,
"person_name": "Peter VAN MELKEBEKE",
"org_rep_person_name": null
},
"summary_narrative": "De buitengewone algemene vergadering van de naamloze vennootschap AUGUSTINE THERAPEUTICS heeft besloten de activiteiten van de vennootschap voort te zetten, ondanks dat het netto-actief gedaald is tot minder dan de helft van het kapitaal. De vergadering heeft ook besloten tot vernietiging van niet-toegekende ESOP-inschrijvingsrechten en de uitgifte van nieuwe ESOP-inschrijvingsrechten. Daarnaast is een kapitaalverhoging door inbrengen in geld beslist, onder een opschortende voorwaarde.",
"co_filed_documents": [
"een uitgifte van het proces-verbaal",
"het verslag van de raad van bestuur",
"het verslag van de commissaris opgesteld overeenkomstig artikelen 7:155 en 7:180 van het Wetboek van vennootschappen en verenigingen",
"het eenparige schriftelijke besluiten van de raad van bestuur"
],
"detected_real_type": "other",
"referenced_correction": null,
"should_reroute_to_category": "capital_shares"
}21-05-2025 2 administrateurs nommés
- Pascale Florence Geneviève Witz — Bestuurder
- Pascale Florence Geneviève Witz — Voorzitter
Détails techniques
{
"events": [
{
"kind": "director_in",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Pascale Florence Genevi\u00E8ve Witz",
"address": "Gaston Geenslaan 3, 3001 Leuven",
"birth_date": null,
"profession": null,
"birth_place": null
},
"reason": null,
"subkind": "regular",
"via_org": null,
"statutory": "statutair",
"compensated": true,
"effective_date": null,
"evidence_quote": "De Aandeelhouders besluiten mevrouw Pascale Florence Genevi\u00E8ve Witz, houdende de Franse nationaliteit, keuze van woonplaats doende op de zetel van de Vennootschap te Gaston Geenslaan 3, 3001 Leuven, Belgi\u00EB, te benoemen als bestuurder van de Vennootschap en, voor zover als nodig, als onafhankelijke b",
"decharge_status": null,
"mandate_duration": {
"kind": "until_agm_year",
"value": "2031"
},
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": null
},
{
"kind": "director_in",
"role": "voorzitter",
"person": {
"rrn": null,
"name": "Pascale Florence Genevi\u00E8ve Witz",
"address": "Gaston Geenslaan 3, 3001 Leuven",
"birth_date": null,
"profession": null,
"birth_place": null
},
"reason": null,
"subkind": "regular",
"via_org": null,
"statutory": "statutair",
"compensated": true,
"effective_date": null,
"evidence_quote": "De Aandeelhouders besluiten mevrouw Pascale Florence Genevi\u00E8ve Witz, houdende de Franse nationaliteit, keuze van woonplaats doende op de zetel van de Vennootschap te Gaston Geenslaan 3, 3001 Leuven, Belgi\u00EB, te benoemen als bestuurder van de Vennootschap en, voor zover als nodig, als onafhankelijke b",
"decharge_status": null,
"mandate_duration": {
"kind": "until_agm_year",
"value": "2031"
},
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": null
}
],
"notary": {
"name": null,
"firm_city": null,
"firm_name": null,
"office_city": null,
"is_associated": false
},
"act_meta": {
"language": "nl",
"pub_date": "2025-05-21",
"filing_date": "2025-05-13",
"act_kind_objet": "Benoeming bestuurder en voorzitter"
},
"decisions": [
{
"body": "enig_aandeelhouder_schriftelijk",
"date": "2025-03-01",
"unanimous": true
}
],
"is_correction": false,
"subject_company": {
"kbo": "0722.705.230",
"name_full": "Augustine Therapeutics",
"legal_form": "NV"
},
"publication_proxy": {
"kind": "person",
"org_kbo": null,
"org_name": null,
"person_name": "Gerhard Koenig",
"org_rep_person_name": null,
"person_role_at_subject": "Persoon belast met dageljks bestuur"
},
"co_filed_documents": [],
"corrected_publication_numac": null
}12-02-2025 7 administrateurs nommés, 6 démissionnaires
- CAMPÀS MOYA Clara — Bestuurder
- COUTANCEAU Emmanuelle — Bestuurder
- AINOUCHE Mahieddine El Mahdi — Bestuurder
- DE TAEYE Bart — Bestuurder
- KOENIG Gerhard — Bestuurder
- Gerhard Koenig — Dagelijks bestuur
- Francisco Orellana — Dagelijks bestuur
- CAMPÀS MOYA Clara — Bestuurder
Notaire:
Peter VAN MELKEBEKE · BrusselÉtude:
BERQUIN NOTARISSEN
Détails techniques
{
"events": [
{
"kind": "director_out",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "CAMP\u00C0S MOYA Clara",
"address": null,
"birth_date": null,
"profession": null,
"birth_place": null
},
"reason": null,
"subkind": null,
"via_org": null,
"statutory": null,
"compensated": null,
"effective_date": null,
"evidence_quote": "",
"decharge_status": null,
"mandate_duration": null,
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": null
},
{
"kind": "director_out",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "CAPOEN Ward",
"address": null,
"birth_date": null,
"profession": null,
"birth_place": null
},
"reason": null,
"subkind": null,
"via_org": null,
"statutory": null,
"compensated": null,
"effective_date": null,
"evidence_quote": "",
"decharge_status": null,
"mandate_duration": null,
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": null
},
{
"kind": "director_out",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "CELANIRE Sylvain",
"address": null,
"birth_date": null,
"profession": null,
"birth_place": null
},
"reason": null,
"subkind": null,
"via_org": null,
"statutory": null,
"compensated": null,
"effective_date": null,
"evidence_quote": "",
"decharge_status": null,
"mandate_duration": null,
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": null
},
{
"kind": "director_out",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "DE TAEYE Bart",
"address": null,
"birth_date": null,
"profession": null,
"birth_place": null
},
"reason": null,
"subkind": null,
"via_org": {
"kbo": null,
"name": "Participatiemaatschappij Vlaanderen",
"address": null,
"country": null,
"legal_form": null
},
"statutory": null,
"compensated": null,
"effective_date": null,
"evidence_quote": "",
"decharge_status": null,
"mandate_duration": null,
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": null
},
{
"kind": "director_out",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "KOENIG Gerhard",
"address": null,
"birth_date": null,
"profession": null,
"birth_place": null
},
"reason": null,
"subkind": null,
"via_org": null,
"statutory": null,
"compensated": null,
"effective_date": null,
"evidence_quote": "",
"decharge_status": null,
"mandate_duration": null,
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": null
},
{
"kind": "director_out",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "HURIEZ Alain",
"address": null,
"birth_date": null,
"profession": null,
"birth_place": null
},
"reason": null,
"subkind": null,
"via_org": null,
"statutory": null,
"compensated": null,
"effective_date": null,
"evidence_quote": "",
"decharge_status": null,
"mandate_duration": null,
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": null
},
{
"kind": "director_in",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "CAMP\u00C0S MOYA Clara",
"address": null,
"birth_date": "1976-01-02",
"profession": null,
"birth_place": "La Roca Del Valles, Barcelona"
},
"reason": null,
"subkind": null,
"via_org": {
"kbo": null,
"name": "Sabadell Asabys Health Innovation Investments II F.C.R.",
"address": null,
"country": null,
"legal_form": null
},
"statutory": null,
"compensated": false,
"effective_date": null,
"evidence_quote": "",
"decharge_status": null,
"mandate_duration": {
"kind": "until_agm_year",
"value": "2031"
},
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": null
},
{
"kind": "director_in",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "COUTANCEAU Emmanuelle",
"address": null,
"birth_date": "1980-05-08",
"profession": null,
"birth_place": "Poitiers"
},
"reason": null,
"subkind": null,
"via_org": {
"kbo": null,
"name": "Novo Holdings A/S",
"address": null,
"country": null,
"legal_form": null
},
"statutory": null,
"compensated": false,
"effective_date": null,
"evidence_quote": "",
"decharge_status": null,
"mandate_duration": {
"kind": "until_agm_year",
"value": "2031"
},
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": null
},
{
"kind": "director_in",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "AINOUCHE Mahieddine El Mahdi",
"address": null,
"birth_date": "1987-01-17",
"profession": null,
"birth_place": "Algiers"
},
"reason": null,
"subkind": null,
"via_org": {
"kbo": null,
"name": "Jeito II SLP",
"address": null,
"country": null,
"legal_form": null
},
"statutory": null,
"compensated": false,
"effective_date": null,
"evidence_quote": "",
"decharge_status": null,
"mandate_duration": {
"kind": "until_agm_year",
"value": "2031"
},
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": null
},
{
"kind": "director_in",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "DE TAEYE Bart",
"address": null,
"birth_date": "1977-12-06",
"profession": null,
"birth_place": "Leuven"
},
"reason": null,
"subkind": null,
"via_org": {
"kbo": null,
"name": "Participatiemaatschappij Vlaanderen",
"address": null,
"country": null,
"legal_form": null
},
"statutory": null,
"compensated": false,
"effective_date": null,
"evidence_quote": "",
"decharge_status": null,
"mandate_duration": {
"kind": "until_agm_year",
"value": "2031"
},
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": null
},
{
"kind": "director_in",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "KOENIG Gerhard",
"address": null,
"birth_date": "1960-08-29",
"profession": null,
"birth_place": "Ellwangen"
},
"reason": null,
"subkind": null,
"via_org": null,
"statutory": null,
"compensated": false,
"effective_date": null,
"evidence_quote": "",
"decharge_status": null,
"mandate_duration": {
"kind": "until_agm_year",
"value": "2031"
},
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": null
},
{
"kind": "decharge_granted",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "CAMP\u00C0S MOYA Clara",
"address": null,
"birth_date": null,
"profession": null,
"birth_place": null
},
"reason": null,
"subkind": null,
"via_org": null,
"statutory": null,
"compensated": null,
"effective_date": null,
"evidence_quote": "",
"decharge_status": "granted",
"mandate_duration": null,
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": null
},
{
"kind": "decharge_granted",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "CAPOEN Ward",
"address": null,
"birth_date": null,
"profession": null,
"birth_place": null
},
"reason": null,
"subkind": null,
"via_org": null,
"statutory": null,
"compensated": null,
"effective_date": null,
"evidence_quote": "",
"decharge_status": "granted",
"mandate_duration": null,
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": null
},
{
"kind": "decharge_granted",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "CELANIRE Sylvain",
"address": null,
"birth_date": null,
"profession": null,
"birth_place": null
},
"reason": null,
"subkind": null,
"via_org": null,
"statutory": null,
"compensated": null,
"effective_date": null,
"evidence_quote": "",
"decharge_status": "granted",
"mandate_duration": null,
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": null
},
{
"kind": "decharge_granted",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "DE TAEYE Bart",
"address": null,
"birth_date": null,
"profession": null,
"birth_place": null
},
"reason": null,
"subkind": null,
"via_org": {
"kbo": null,
"name": "Participatiemaatschappij Vlaanderen",
"address": null,
"country": null,
"legal_form": null
},
"statutory": null,
"compensated": null,
"effective_date": null,
"evidence_quote": "",
"decharge_status": "granted",
"mandate_duration": null,
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": null
},
{
"kind": "decharge_granted",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "KOENIG Gerhard",
"address": null,
"birth_date": null,
"profession": null,
"birth_place": null
},
"reason": null,
"subkind": null,
"via_org": null,
"statutory": null,
"compensated": null,
"effective_date": null,
"evidence_quote": "",
"decharge_status": "granted",
"mandate_duration": null,
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": null
},
{
"kind": "decharge_granted",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "HURIEZ Alain",
"address": null,
"birth_date": null,
"profession": null,
"birth_place": null
},
"reason": null,
"subkind": null,
"via_org": null,
"statutory": null,
"compensated": null,
"effective_date": null,
"evidence_quote": "",
"decharge_status": "granted",
"mandate_duration": null,
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": null
},
{
"kind": "delegation_dagelijks_bestuur_in",
"role": "dagelijks_bestuur",
"person": {
"rrn": null,
"name": "Gerhard Koenig",
"address": null,
"birth_date": null,
"profession": null,
"birth_place": null
},
"reason": null,
"subkind": null,
"via_org": null,
"statutory": null,
"compensated": null,
"effective_date": null,
"evidence_quote": "",
"decharge_status": null,
"mandate_duration": null,
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": "immediate"
},
{
"kind": "delegation_dagelijks_bestuur_in",
"role": "dagelijks_bestuur",
"person": {
"rrn": null,
"name": "Francisco Orellana",
"address": null,
"birth_date": null,
"profession": null,
"birth_place": null
},
"reason": null,
"subkind": null,
"via_org": {
"kbo": null,
"name": "CxO SA",
"address": null,
"country": null,
"legal_form": null
},
"statutory": null,
"compensated": null,
"effective_date": null,
"evidence_quote": "",
"decharge_status": null,
"mandate_duration": null,
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": "immediate"
},
{
"kind": "substantive_delegation",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Gerhard Koenig",
"address": null,
"birth_date": null,
"profession": null,
"birth_place": null
},
"reason": null,
"subkind": null,
"via_org": null,
"statutory": null,
"compensated": null,
"effective_date": null,
"evidence_quote": "",
"decharge_status": null,
"mandate_duration": null,
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": null
}
],
"notary": {
"name": "Peter VAN MELKEBEKE",
"firm_city": null,
"firm_name": "BERQUIN NOTARISSEN",
"office_city": "Brussel",
"is_associated": true
},
"act_meta": {
"language": "nl",
"pub_date": "2025-02-12",
"filing_date": "2025-02-10",
"act_kind_objet": "Onderwerp akte:"
},
"decisions": [
{
"body": "buitengewone_algemene_vergadering",
"date": "2025-01-31",
"unanimous": null
}
],
"is_correction": false,
"subject_company": {
"kbo": "0722.705.230",
"name_full": "AUGUSTINE THERAPEUTICS",
"legal_form": "NV"
},
"publication_proxy": {
"kind": "person",
"org_kbo": null,
"org_name": null,
"person_name": "Peter VAN MELKEBEKE",
"org_rep_person_name": null,
"person_role_at_subject": "notaris"
},
"co_filed_documents": [
"een uitgifte van het proces-verbaal",
"dertien volmachten",
"de geco\u00F6rdineerde tekst van statuten",
"het verslag van de raad van bestuur",
"het verslag van de commissaris opgesteld overeenkomstig artikel 7:155 van het Wetboek van vennootschappen en verenigingen",
"het verslag van de raad van bestuur en het verslag van de commissaris opgesteld overeenkomstig artikelen 7:155 en 7:180 van het Wetboek van vennootschappen en verenigingen",
"het verslag van de raad van bestuur d.d. 12 november 2024"
],
"corrected_publication_numac": null
}12-02-2025 Modification des statuts — traduction des statuts, coordination des statuts et refonte complète des statuts
Résumé:
De vennootschap heeft tot voorwerp het exploiteren van biologische, biochemische of andere producten, processen en technologieën in de life sciences sector, het ontwerpen en maken van instrumenten, he…Notaire:
Peter VAN MELKEBEKE · BrusselÉtude:
BERQUIN NOTARISSEN
Détails techniques
{
"notary": {
"name": "Peter VAN MELKEBEKE",
"firm_city": null,
"firm_name": "BERQUIN NOTARISSEN",
"office_city": "Brussel",
"is_associated": true
},
"act_meta": {
"language": "nl",
"pub_date": "2025-02-12",
"filing_date": "2025-02-10",
"act_kind_objet": "ONTSLAGEN, BENOEMINGEN, KAPITAAL, AANDELEN, STATUTEN (VERTALING, COORDINATIE, OVERIGE WIJZIGINGEN)"
},
"decision": {
"body": "buitengewone_algemene_vergadering",
"act_date": "2025-01-31",
"unanimous": null
},
"statute_change": {
"kinds": [
"translation",
"coordination",
"full_restatement",
"name_change",
"seat_region_change",
"object_change",
"duration_change",
"share_class_creation",
"wvv_adaptation"
],
"scope": "full_restatement",
"trigger": "capital_change_consequence",
"language_after": "nl",
"language_before": "nl"
},
"bedrijfsrevisor": null,
"subject_company": {
"kbo": "0722.705.230",
"name_full_after": "AUGUSTINE THERAPEUTICS",
"legal_form_after": "Naamloze vennootschap",
"name_full_before": "AUGUSTINE THERAPEUTICS",
"current_zetel_raw": "Gaston Geenslaan 3, 3001 Leuven",
"legal_form_before": "Naamloze vennootschap"
},
"special_mandates": [
{
"holder_kbo": null,
"holder_name": "Gerhard Koenig",
"scope_categories": [
"kbo",
"ubo",
"btw",
"estox",
"publication",
"tax"
],
"with_substitution": true
}
],
"articles_modified": [
{
"summary": "Wijziging van artikel 5 van de statuten teneinde de statuten in overeenstemming te brengen met de beslissing tot kapitaalverhoging.",
"new_text": null,
"change_kind": "amended",
"article_title": null,
"article_number": "5"
},
{
"summary": "De vennootschap neemt de vorm aan van een naamloze vennootschap en draagt de naam \u0022Augustine Therapeutics\u0022.",
"new_text": "De vennootschap neemt de vorm aan van een naamloze vennootschap en draagt de naam \u0022Augustine Therapeutics\u0022.\nDeze naam moet steeds worden voorafgegaan of gevolgd door de woorden \u0022naamloze\nvennootschap\u0022 of de afkorting \u0022NV\u0022.",
"change_kind": "restated",
"article_title": "RECHTSVORM EN NAAM",
"article_number": "1"
},
{
"summary": "De zetel is gevestigd in het Vlaams Gewest. De raad van bestuur draagt zorg voor de publicatie van elke verplaatsing van de zetel.",
"new_text": "De zetel is gevestigd in het Vlaams Gewest. De raad van bestuur draagt zorg voor de publicatie van\nelke verplaatsing van de zetel van de vennootschap in de Bijlagen bij het Belgisch Staatsblad.\nDe raad van bestuur is eveneens bevoegd kantoren, bedrijfszetels, bijkantoren en",
"change_kind": "restated",
"article_title": "ZETEL",
"article_number": "2"
},
{
"summary": "De vennootschap heeft tot voorwerp het exploiteren van biologische, biochemische of andere producten, processen en technologie\u00EBn in de life sciences sector.",
"new_text": "De vennootschap heeft tot voorwerp, in Belgi\u00EB en in het buitenland, in eigen naam of in naam van\nderden, voor eigen rekening of voor rekening van derden, alleen of in participatie:\n(a) het exploiteren van biologische, biochemische of andere producten, processen en technologie\u00EBn",
"change_kind": "restated",
"article_title": "VOORWERP",
"article_number": "3"
},
{
"summary": "De vennootschap wordt opgericht voor een onbeperkte duur vanaf de datum van haar oprichting.",
"new_text": "De vennootschap wordt opgericht voor een onbeperkte duur vanaf de datum van haar oprichting.",
"change_kind": "restated",
"article_title": "DUUR",
"article_number": "4"
},
{
"summary": "Het geplaatst kapitaal bedraagt EUR 52.329.665,17, vertegenwoordigd door 38.519.773 aandelen.",
"new_text": "Het geplaatst kapitaal bedraagt twee\u00EBnvijftig miljoen driehonderdnegenentwintigduizend\nzeshonderdvijfenzestig euro en zeventien eurocent (EUR 52.329.665,17).\nHet wordt vertegenwoordigd door achtendertig miljoen vijfhonderdnegentienduizend",
"change_kind": "restated",
"article_title": "GEPLAATST KAPITAAL",
"article_number": "5"
},
{
"summary": "De vennootschap wordt bestuurd door een raad van bestuur die telt minstens vijf en maximaal negen bestuurders.",
"new_text": "De vennootschap wordt bestuurd door een raad van bestuur. De raad van bestuur telt minstens vijf\n(5) en maximaal negen (9) bestuurders, waarvan de volgende bestuurders als volgt zullen worden",
"change_kind": "restated",
"article_title": "SAMENSTELLING VAN DE RAAD VAN BESTUUR",
"article_number": "16"
},
{
"summary": "De raad van bestuur is bevoegd om alle handelingen te verrichten die nodig of dienstig zijn tot verwezenlijking van het voorwerp van de vennootschap.",
"new_text": "De raad van bestuur is bevoegd om alle handelingen te verrichten die nodig of dienstig zijn tot\nverwezenlijking van het voorwerp van de vennootschap, met uitzondering van die handelingen",
"change_kind": "restated",
"article_title": "BEVOEGDHEDEN VAN DE RAAD VAN BESTUUR",
"article_number": "21"
},
{
"summary": "De raad van bestuur kan het dagelijks bestuur opdragen aan \u00E9\u00E9n of meer bestuurders die de titel van gedelegeerd-bestuurder(s) zullen voeren.",
"new_text": "De raad van bestuur kan het dagelijks bestuur van de vennootschap opdragen aan \u00E9\u00E9n of meer\nbestuurders die de titel van gedelegeerd-bestuurder(s) zullen voeren, en/of aan \u00E9\u00E9n of meer",
"change_kind": "restated",
"article_title": "DAGELIJKS BESTUUR",
"article_number": "23"
},
{
"summary": "De vennootschap wordt rechtsgeldig vertegenwoordigd door twee gezamenlijk optredende bestuurders.",
"new_text": "De vennootschap wordt in al haar handelingen, met inbegrip van de vertegenwoordiging in rechte,\nrechtsgeldig vertegenwoordigd door twee gezamenlijk optredende bestuurders die ten aanzien van",
"change_kind": "restated",
"article_title": "VERTEGENWOORDIGING",
"article_number": "24"
},
{
"summary": "Er wordt ieder jaar een algemene vergadering gehouden op de tweede woensdag van de maand mei.",
"new_text": "Er wordt ieder jaar een algemene vergadering gehouden op de tweede woensdag van de maand mei\nom 11 uur (Belgische tijd). Indien deze dag wettelijke feestdag is, wordt de vergadering op de eerst",
"change_kind": "restated",
"article_title": "VERGADERINGEN",
"article_number": "27"
},
{
"summary": "Om tot de algemene vergadering te worden toegelaten, moeten de eigenaars van effecten op naam binnen de in de oproeping vermelde termijn aan de raad van bestuur hun inzicht te kennen geven.",
"new_text": "Om tot de algemene vergadering te worden toegelaten, moeten de eigenaars van effecten op naam\nbinnen de in de oproeping vermelde termijn aan de raad van bestuur hun inzicht te kennen geven de",
"change_kind": "restated",
"article_title": "TOELATINGSVOORWAARDEN",
"article_number": "29"
},
{
"summary": "Iedere aandeelhouder kan per brief, elektronische post of op een andere schriftelijke wijze een volmacht geven om zich op de algemene vergadering te vertegenwoordigen.",
"new_text": "Iedere aandeelhouder kan per brief, elektronische post of op een andere schriftelijke wijze een\nvolmacht geven om zich op de algemene vergadering te vertegenwoordigen. De lasthebber moet",
"change_kind": "restated",
"article_title": "VERTEGENWOORDIGING",
"article_number": "30"
},
{
"summary": "Ieder aandeel geeft recht op \u00E9\u00E9n stem.",
"new_text": "Ieder aandeel geeft recht op \u00E9\u00E9n stem.\nDe houders van obligaties, inschrijvingsrechten en certificaten die met medewerking van de",
"change_kind": "restated",
"article_title": "AANTAL STEMMEN - UITOEFENING VAN HET STEMRECHT",
"article_number": "33"
},
{
"summary": "Het boekjaar begint op 1 januari en eindigt op 31 december van elk jaar.",
"new_text": "Het boekjaar begint op 1 januari en eindigt op 31 december van elk jaar.",
"change_kind": "restated",
"article_title": "JAARREKENING",
"article_number": "36"
},
{
"summary": "De gewone algemene vergadering hoort desgevallend het jaarverslag en het verslag van de commissaris(sen) en beslist over de goedkeuring van de jaarrekening.",
"new_text": "De gewone algemene vergadering hoort desgevallend het jaarverslag en het verslag van de\ncommissaris(sen) en beslist over de goedkeuring van de jaarrekening.\nNa goedkeuring van de jaarrekening spreekt de algemene vergadering zich uit, bij afzonderlijke",
"change_kind": "restated",
"article_title": "GOEDKEURING VAN DE JAARREKENING",
"article_number": "37"
},
{
"summary": "Jaarlijks wordt van de netto-winst een bedrag van vijf procent (5%) voorafgenomen tot vorming van een wettelijke reserve.",
"new_text": "Jaarlijks wordt van de netto-winst vermeld in de jaarrekening een bedrag van vijf procent (5%)\nvoorafgenomen tot vorming van een wettelijke reserve; deze voorafneming is niet meer verplicht",
"change_kind": "restated",
"article_title": "WINSTUITKERING",
"article_number": "38"
},
{
"summary": "Wanneer het netto-actief is gedaald tot minder dan de helft van het geplaatst kapitaal, moeten de bestuurders de vraag van de ontbinding van de vennootschap voorleggen aan de algemene vergadering.",
"new_text": "Wanneer ten gevolge van geleden verlies het netto-actief is gedaald tot minder dan de helft van het\ngeplaatst kapitaal, moeten de bestuurders de vraag van de ontbinding van de vennootschap en",
"change_kind": "restated",
"article_title": "VERVROEGDE ONTBINDING",
"article_number": "40"
},
{
"summary": "In geval van ontbinding van de vennootschap, geschiedt de vereffening in \u00E9\u00E9n akte overeenkomstig de bepalingen van het Wetboek van vennootschappen en verenigingen.",
"new_text": "In geval van ontbinding van de vennootschap, om welke reden of op welk tijdstip ook, geschiedt de\nvereffening in \u00E9\u00E9n akte overeenkomstig de bepalingen van het Wetboek van vennootschappen en",
"change_kind": "restated",
"article_title": "VEREFFENING",
"article_number": "41"
},
{
"summary": "Houders van Series A Aandelen hebben recht op een liquiditeitspreferentie bij bepaalde gebeurtenissen, zoals een liquidatie of verkoop, gelijk aan de inschrijvingsprijs vermeerderd met een voorafgaande betaling.",
"new_text": "42.1. Indien, na goedkeuring van de raad van bestuur (inclusief een Gekwalificeerde\nBestuurdersmeerderheid) en de Series A Bevoorrechte Meerderheid, uitkeringen van opbrengsten of",
"change_kind": "restated",
"article_title": "LIQUIDITEITSPREFERENTIE",
"article_number": "42"
}
],
"governance_change": {
"organ_kind_after": "collegial",
"organ_kind_before": "collegial",
"admin_delegated_added": [
{
"name": "Gerhard Koenig",
"excluded_powers": []
},
{
"name": "CxO SA",
"excluded_powers": []
}
],
"representation_rule_after": "twee_gezamenlijk",
"co_signature_threshold_eur": null,
"representation_rule_before": "twee_gezamenlijk"
},
"publication_proxy": {
"kind": "person",
"org_kbo": null,
"org_name": null,
"person_name": "Peter VAN MELKEBEKE",
"org_rep_person_name": null
},
"co_filed_documents": [
"een uitgifte van het proces-verbaal",
"dertien volmachten",
"de geco\u00F6rdineerde tekst van statuten",
"het verslag van de raad van bestuur",
"het verslag van de commissaris opgesteld overeenkomstig artikel 7:155 van het Wetboek van vennootschappen en verenigingen",
"het verslag van de raad van bestuur en het verslag van de commissaris opgesteld overeenkomstig artikelen 7:155 en 7:180 van het Wetboek van vennootschappen en verenigingen",
"het verslag van de raad van bestuur d.d. 12 november 2024"
],
"shareholder_rights": {
"quorum_rules_changed": false,
"liquidation_preference_text": "42.1. Indien, na goedkeuring van de raad van bestuur (inclusief een Gekwalificeerde Bestuurdersmeerderheid) en de Series A Bevoorrechte Meerderheid, uitkeringen van opbrengsten of activa worden gedaan aan de aandeelhouder als gevolg van (i) een betaling van dividenden, kapitaalvermindering, of aandeleninkoop, of andere uitkeringen aan aandeelhouders, (ii) een faillissement, liquidatie, ontbinding of reorganisatie van de vennootschap, (iii) een verkoop van alle, substantieel alle, of een substantieel deel van de activa en/of activiteiten (inclusief intellectuele eigendomsrechten) van de vennootschap, (iv) een fusie, consolidatie of overname, waarbij de vennootschap of haar dochtervennootschappen betrokken zijn en waarbij de vennootschap of haar dochtervennootschappen niet de overlevende entiteit zijn, (v) een beursintroductie die geen Gekwalificeerde IPO is, (vi) een reverse take-over, (vii) het in licentie geven van alle, substantieel alle, of een substantieel deel van, de intellectuele eigendomsrechten van de vennootschap op een manier die kan worden beschouwd als gelijkwaardig aan een exit (te kwalificeren op basis van een beslissing van de raad van bestuur en goed te keuren door een Series A Bevoorrechte Meerderheid), (viii) een handelsverkoop of elke andere gebeurtenis waarbij de controle over de vennootschap wordt overgedragen in het bijzonder de verkoop van alle of vrijwel alle aandelen van de vennootschap (tegen betaling in contanten of in aandelen) (inclusief, om twijfel te vermijden, ingevolge de toepassing van het Pro Rata Volgrecht, het Controle Volgrecht of de Drag Along Rechten), (ix) een verkoop of andere overdracht van aandelen in de vennootschap waarbij aan alle aandeelhouders wordt aangeboden om aandelen pro rata te verkopen of anderszins over te dragen of (x) enige andere gebeurtenis met in wezen hetzelfde economische effect als, of een combinatie van, de gebeurtenissen uiteengezet in (i) tot (ix) hierboven (een \u0022Liquiditeitsgebeurtenis\u0022), zullen e",
"voorkeurrecht_rules_changed": true,
"aandelenoverdracht_restrictions_changed": false
},
"voorwerp_change_summary": "De vennootschap heeft tot voorwerp het exploiteren van biologische, biochemische of andere producten, processen en technologie\u00EBn in de life sciences sector, het ontwerpen en maken van instrumenten, het wereldwijd verspreiden en verkopen van deze producten, het oprichten en deelnemen in vennootschappen, het financieren van ondernemingen, het verstrekken van garanties, het verkrijgen en beheren van vermogenswaarden, het verhandelen van valuta en effecten, het verkrijgen en beheren van octrooien en",
"capital_structure_change": {
"operations": [
"capital_increase_cash",
"share_class_creation",
"share_cancellation",
"wvv_capital_release"
],
"split_ratio": null,
"shares_after": 38519773,
"shares_before": 38519773,
"capital_after_eur": 52329665.17,
"capital_before_eur": 52329665.44,
"share_classes_after": [
{
"count": 7901926,
"label": "Seed Aandelen",
"rights_summary": "Deelrechten in winsten pro rata temporis vanaf inschrijving.",
"voting_per_share": null
},
{
"count": 30617847,
"label": "Series A Aandelen",
"rights_summary": "Deelrechten in winsten pro rata temporis vanaf inschrijving.",
"voting_per_share": null
},
{
"count": 30,
"label": "Seed Anti-dilutie Inschrijvingsrechten",
"rights_summary": "Inschrijvingsrechten voor uitgifte van nieuwe aandelen.",
"voting_per_share": null
},
{
"count": 50,
"label": "Series A Anti-dilutie Inschrijvingsrechten",
"rights_summary": "Inschrijvingsrechten voor uitgifte van nieuwe aandelen.",
"voting_per_share": null
},
{
"count": 80,
"label": "Extended Series A Anti-dilutie Inschrijvingsrechten",
"rights_summary": "Inschrijvingsrechten voor uitgifte van nieuwe aandelen.",
"voting_per_share": null
},
{
"count": 80,
"label": "Extended Series A Schadeloosstelling Inschrijvingsrechten",
"rights_summary": "Inschrijvingsrechten voor uitgifte van nieuwe aandelen.",
"voting_per_share": null
}
]
},
"coordinated_text_lineage": null
}12-02-2025 Augmentation de capital de 36.999.999,73 € à 52.329.665,17 €
- €15.329.665,44 → €52.329.665,17
- Inbreng in geld · Apport en numéraire
Notaire:
Peter VAN MELKEBEKE · BrusselÉtude:
BERQUIN NOTARISSEN
Détails techniques
{
"events": [
{
"kind": "capital_increase",
"after_eur": 52329665.17,
"delta_eur": 36999999.73,
"before_eur": 15329665.44,
"share_emission": {
"agio_eur": null,
"share_form": "no_nominal_value",
"share_class": "A",
"n_new_shares": 19234968,
"with_new_shares": true,
"nominal_value_eur": null,
"issue_price_per_share_eur": 1.92358
},
"decrease_purpose": null,
"contribution_type": "geld",
"paid_up_delta_eur": 36999999.73,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
},
{
"kind": "share_class_creation",
"after_eur": null,
"delta_eur": null,
"before_eur": null,
"share_emission": {
"agio_eur": null,
"share_form": null,
"share_class": null,
"n_new_shares": null,
"with_new_shares": false,
"nominal_value_eur": null,
"issue_price_per_share_eur": null
},
"decrease_purpose": null,
"contribution_type": null,
"paid_up_delta_eur": null,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
},
{
"kind": "share_class_creation",
"after_eur": null,
"delta_eur": null,
"before_eur": null,
"share_emission": {
"agio_eur": null,
"share_form": null,
"share_class": null,
"n_new_shares": null,
"with_new_shares": false,
"nominal_value_eur": null,
"issue_price_per_share_eur": null
},
"decrease_purpose": null,
"contribution_type": null,
"paid_up_delta_eur": null,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
},
{
"kind": "share_class_creation",
"after_eur": null,
"delta_eur": null,
"before_eur": null,
"share_emission": {
"agio_eur": null,
"share_form": null,
"share_class": null,
"n_new_shares": null,
"with_new_shares": false,
"nominal_value_eur": null,
"issue_price_per_share_eur": null
},
"decrease_purpose": null,
"contribution_type": null,
"paid_up_delta_eur": null,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
},
{
"kind": "share_class_creation",
"after_eur": null,
"delta_eur": null,
"before_eur": null,
"share_emission": {
"agio_eur": null,
"share_form": null,
"share_class": null,
"n_new_shares": null,
"with_new_shares": false,
"nominal_value_eur": null,
"issue_price_per_share_eur": null
},
"decrease_purpose": null,
"contribution_type": null,
"paid_up_delta_eur": null,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
},
{
"kind": "share_class_creation",
"after_eur": null,
"delta_eur": null,
"before_eur": null,
"share_emission": {
"agio_eur": null,
"share_form": null,
"share_class": null,
"n_new_shares": null,
"with_new_shares": false,
"nominal_value_eur": null,
"issue_price_per_share_eur": null
},
"decrease_purpose": null,
"contribution_type": null,
"paid_up_delta_eur": null,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
},
{
"kind": "share_class_creation",
"after_eur": null,
"delta_eur": null,
"before_eur": null,
"share_emission": {
"agio_eur": null,
"share_form": null,
"share_class": null,
"n_new_shares": null,
"with_new_shares": false,
"nominal_value_eur": null,
"issue_price_per_share_eur": null
},
"decrease_purpose": null,
"contribution_type": null,
"paid_up_delta_eur": null,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
},
{
"kind": "share_class_creation",
"after_eur": null,
"delta_eur": null,
"before_eur": null,
"share_emission": {
"agio_eur": null,
"share_form": null,
"share_class": null,
"n_new_shares": null,
"with_new_shares": false,
"nominal_value_eur": null,
"issue_price_per_share_eur": null
},
"decrease_purpose": null,
"contribution_type": null,
"paid_up_delta_eur": null,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
},
{
"kind": "share_class_creation",
"after_eur": null,
"delta_eur": null,
"before_eur": null,
"share_emission": {
"agio_eur": null,
"share_form": null,
"share_class": null,
"n_new_shares": null,
"with_new_shares": false,
"nominal_value_eur": null,
"issue_price_per_share_eur": null
},
"decrease_purpose": null,
"contribution_type": null,
"paid_up_delta_eur": null,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
},
{
"kind": "share_class_creation",
"after_eur": null,
"delta_eur": null,
"before_eur": null,
"share_emission": {
"agio_eur": null,
"share_form": null,
"share_class": null,
"n_new_shares": null,
"with_new_shares": false,
"nominal_value_eur": null,
"issue_price_per_share_eur": null
},
"decrease_purpose": null,
"contribution_type": null,
"paid_up_delta_eur": null,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
}
],
"notary": {
"name": "Peter VAN MELKEBEKE",
"firm_city": null,
"firm_name": "BERQUIN NOTARISSEN",
"office_city": "Brussel",
"is_associated": true
},
"act_meta": {
"language": "nl",
"pub_date": "2025-02-12",
"filing_date": "2025-02-10",
"act_kind_objet": "Onderwerp akte:"
},
"decision": {
"body": "buitengewone_algemene_vergadering",
"act_date": "2025-01-31",
"unanimous": null,
"under_authorized_capital": true,
"underlying_resolution_date": null
},
"bedrijfsrevisor": null,
"subject_company": {
"kbo": "0722.705.230",
"name_full": "AUGUSTINE THERAPEUTICS",
"legal_form": "Naamloze vennootschap",
"is_foreign_registered": false
},
"publication_proxy": {
"kind": "none",
"org_kbo": null,
"org_name": null,
"person_name": null,
"org_rep_person_name": null,
"person_role_at_subject": null
},
"co_filed_documents": [
"expedition",
"plan financier",
"bankattest",
"verslag bedrijfsrevisor"
],
"shareholders_after": [],
"share_classes_after": [
{
"n_shares": 7901926,
"class_name": "Seed Aandelen",
"capital_share_eur": null,
"voting_rights_per_share": 1.0
},
{
"n_shares": 30617847,
"class_name": "Series A Aandelen",
"capital_share_eur": null,
"voting_rights_per_share": 1.0
}
]
}2024
01-07-2024 6 administrateurs nommés, 7 démissionnaires
- CAMPÀS MOYA Clara — Bestuurder
- DE TAEYE Bart — Bestuurder
- HURIEZ Alain — Bestuurder
- CAPOEN Ward — Bestuurder
- KOENIG Gerhard — Bestuurder
- CELANIRE Sylvain — Bestuurder
- DE TAEYE Bart — Bestuurder
- CAPOEN Ward — Bestuurder
Notaire:
Tim CARNEWAL · BrusselÉtude:
BERQUIN NOTARISSEN
Détails techniques
{
"events": [
{
"kind": "decharge_granted",
"role": "voorzitter",
"person": null,
"reason": null,
"subkind": "regular",
"via_org": null,
"statutory": null,
"compensated": null,
"effective_date": null,
"evidence_quote": "",
"decharge_status": "granted",
"mandate_duration": null,
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": null
},
{
"kind": "director_out",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "DE TAEYE Bart",
"address": null,
"birth_date": null,
"profession": null,
"birth_place": null
},
"reason": "eervol",
"subkind": "regular",
"via_org": {
"kbo": null,
"name": "Participatiemaatschappij Vlaanderen",
"address": null,
"country": null,
"legal_form": "NV"
},
"statutory": null,
"compensated": null,
"effective_date": null,
"evidence_quote": "",
"decharge_status": null,
"mandate_duration": null,
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": null
},
{
"kind": "director_out",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "CAPOEN Ward",
"address": null,
"birth_date": null,
"profession": null,
"birth_place": null
},
"reason": "eervol",
"subkind": "regular",
"via_org": null,
"statutory": null,
"compensated": null,
"effective_date": null,
"evidence_quote": "",
"decharge_status": null,
"mandate_duration": null,
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": null
},
{
"kind": "director_out",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "CELANIRE Sylvain",
"address": null,
"birth_date": null,
"profession": null,
"birth_place": null
},
"reason": "eervol",
"subkind": "regular",
"via_org": null,
"statutory": null,
"compensated": null,
"effective_date": null,
"evidence_quote": "",
"decharge_status": null,
"mandate_duration": null,
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": null
},
{
"kind": "director_out",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "GEERS Bart",
"address": null,
"birth_date": null,
"profession": null,
"birth_place": null
},
"reason": "eervol",
"subkind": "regular",
"via_org": null,
"statutory": null,
"compensated": null,
"effective_date": null,
"evidence_quote": "",
"decharge_status": null,
"mandate_duration": null,
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": null
},
{
"kind": "director_out",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "HURIEZ Alain",
"address": null,
"birth_date": null,
"profession": null,
"birth_place": null
},
"reason": "eervol",
"subkind": "regular",
"via_org": null,
"statutory": null,
"compensated": null,
"effective_date": null,
"evidence_quote": "",
"decharge_status": null,
"mandate_duration": null,
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": null
},
{
"kind": "director_out",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "KOENIG Gerhard",
"address": null,
"birth_date": null,
"profession": null,
"birth_place": null
},
"reason": "eervol",
"subkind": "regular",
"via_org": null,
"statutory": null,
"compensated": null,
"effective_date": null,
"evidence_quote": "",
"decharge_status": null,
"mandate_duration": null,
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": null
},
{
"kind": "director_out",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "VAN BIERVLIET J\u00E9r\u00F4me",
"address": null,
"birth_date": null,
"profession": null,
"birth_place": null
},
"reason": "eervol",
"subkind": "regular",
"via_org": null,
"statutory": null,
"compensated": null,
"effective_date": null,
"evidence_quote": "",
"decharge_status": null,
"mandate_duration": null,
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": null
},
{
"kind": "director_in",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "CAMP\u00C0S MOYA Clara",
"address": null,
"birth_date": "1976-01-02",
"profession": null,
"birth_place": "La Roca Del Valles (Barcelona)"
},
"reason": null,
"subkind": "regular",
"via_org": {
"kbo": null,
"name": "Sabadell Asabys Health Innovation Investments II F.C.R. en Sabadell Asabys Health Innovation Investments 2B S.C.R., S.A.",
"address": null,
"country": null,
"legal_form": null
},
"statutory": null,
"compensated": false,
"effective_date": "2024-06-14",
"evidence_quote": "",
"decharge_status": null,
"mandate_duration": {
"kind": "n_years",
"value": "6"
},
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": "immediate"
},
{
"kind": "director_in",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "DE TAEYE Bart",
"address": null,
"birth_date": "1977-12-06",
"profession": null,
"birth_place": "Leuven"
},
"reason": null,
"subkind": "regular",
"via_org": {
"kbo": null,
"name": "Participatiemaatschappij Vlaanderen NV",
"address": null,
"country": null,
"legal_form": "NV"
},
"statutory": null,
"compensated": false,
"effective_date": "2024-06-14",
"evidence_quote": "",
"decharge_status": null,
"mandate_duration": {
"kind": "n_years",
"value": "6"
},
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": "immediate"
},
{
"kind": "director_in",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "HURIEZ Alain",
"address": null,
"birth_date": "1962-08-06",
"profession": null,
"birth_place": "Amiens (Frankrijk)"
},
"reason": null,
"subkind": "regular",
"via_org": {
"kbo": null,
"name": "AFB Seed Fund",
"address": null,
"country": null,
"legal_form": null
},
"statutory": null,
"compensated": false,
"effective_date": "2024-06-14",
"evidence_quote": "",
"decharge_status": null,
"mandate_duration": {
"kind": "n_years",
"value": "6"
},
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": "immediate"
},
{
"kind": "director_in",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "CAPOEN Ward",
"address": null,
"birth_date": "1979-10-25",
"profession": null,
"birth_place": "Roeselare"
},
"reason": null,
"subkind": "regular",
"via_org": {
"kbo": null,
"name": "V-BIO FUND 1 NV",
"address": null,
"country": null,
"legal_form": "NV"
},
"statutory": null,
"compensated": false,
"effective_date": "2024-06-14",
"evidence_quote": "",
"decharge_status": null,
"mandate_duration": {
"kind": "n_years",
"value": "6"
},
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": "immediate"
},
{
"kind": "director_in",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "KOENIG Gerhard",
"address": null,
"birth_date": "1960-08-29",
"profession": null,
"birth_place": "Duitsland"
},
"reason": null,
"subkind": "regular",
"via_org": null,
"statutory": null,
"compensated": false,
"effective_date": "2024-06-14",
"evidence_quote": "",
"decharge_status": null,
"mandate_duration": {
"kind": "n_years",
"value": "6"
},
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": "immediate"
},
{
"kind": "director_in",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "CELANIRE Sylvain",
"address": null,
"birth_date": "1973-05-02",
"profession": "CEO",
"birth_place": "Rouen (Frankrijk)"
},
"reason": null,
"subkind": "regular",
"via_org": null,
"statutory": null,
"compensated": false,
"effective_date": "2024-06-14",
"evidence_quote": "",
"decharge_status": null,
"mandate_duration": {
"kind": "n_years",
"value": "6"
},
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": "immediate"
}
],
"notary": {
"name": "Tim CARNEWAL",
"firm_city": null,
"firm_name": "BERQUIN NOTARISSEN",
"office_city": "Brussel",
"is_associated": true
},
"act_meta": {
"language": "nl",
"pub_date": "2024-07-01",
"filing_date": "2024-06-27",
"act_kind_objet": "Onderwerp akte:"
},
"decisions": [
{
"body": "buitengewone_algemene_vergadering",
"date": "2024-06-14",
"unanimous": null
}
],
"is_correction": false,
"subject_company": {
"kbo": "0722.705.230",
"name_full": "AUGUSTINE THERAPEUTICS",
"legal_form": "NV"
},
"publication_proxy": {
"kind": "person",
"org_kbo": null,
"org_name": null,
"person_name": "Tim CARNEWAL",
"org_rep_person_name": null,
"person_role_at_subject": "notaris"
},
"co_filed_documents": [
"een uitgifte van het proces-verbaal",
"tien volmachten",
"de verslagen van de raad van bestuur en de commissaris in toepassing van artikelen 7:155 en 7:180 van het Wetboek van vennootschappen en verenigingen",
"het verslag van de raad van bestuur opgesteld in toepassing van de artikelen 7:197, \u00A71, eerste lid juncto 7:179, \u00A71, eerste lid van het Wetboek van vennootschappen en verenigingen",
"het verslag van de commissaris opgesteld in toepassing van de artikelen 7:179, \u00A71, tweede lid en 7:197, \u00A71, tweede lid van het Wetboek van vennootschappen en verenigingen",
"de geco\u00F6rdineerde tekst van de statuten"
],
"corrected_publication_numac": null
}01-07-2024 Augmentation de capital de 11.559.993,71 € à 15.329.665,44 €
- €3.769.671,73 → €15.329.665,44
- Inbreng in geld · Apport en numéraire
- 3 kapitaalbewegingen in deze akte
Notaire:
Tim CARNEWAL · BrusselÉtude:
BERQUIN NOTARISSEN
Détails techniques
{
"events": [
{
"kind": "eenhoofdigheid_declaration",
"after_eur": null,
"delta_eur": null,
"before_eur": null,
"decrease_purpose": null,
"contribution_type": null,
"paid_up_delta_eur": null,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
},
{
"kind": "share_class_conversion",
"after_eur": null,
"delta_eur": null,
"before_eur": null,
"decrease_purpose": null,
"contribution_type": null,
"paid_up_delta_eur": null,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
},
{
"kind": "share_class_creation",
"after_eur": null,
"delta_eur": null,
"before_eur": null,
"decrease_purpose": null,
"contribution_type": null,
"paid_up_delta_eur": null,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
},
{
"kind": "capital_increase",
"after_eur": 14192471.28,
"delta_eur": 5957125.48,
"before_eur": 8235345.8,
"share_emission": {
"agio_eur": null,
"share_form": null,
"share_class": "Series A",
"n_new_shares": 3871024,
"with_new_shares": true,
"nominal_value_eur": null,
"issue_price_per_share_eur": null
},
"decrease_purpose": null,
"contribution_type": "inschrijvingsrechten_uitgifte",
"paid_up_delta_eur": null,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": 3871024,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
},
{
"kind": "capital_decrease",
"after_eur": 3769671.73,
"delta_eur": -10422799.55,
"before_eur": 14192471.28,
"decrease_purpose": "loss_absorption",
"contribution_type": null,
"paid_up_delta_eur": null,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
},
{
"kind": "capital_increase",
"after_eur": 15329665.44,
"delta_eur": 11559993.71,
"before_eur": 3769671.73,
"share_emission": {
"agio_eur": null,
"share_form": null,
"share_class": "Series A",
"n_new_shares": 7511855,
"with_new_shares": true,
"nominal_value_eur": null,
"issue_price_per_share_eur": null
},
"decrease_purpose": null,
"contribution_type": "geld",
"paid_up_delta_eur": 11559993.71,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": 7511855,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
},
{
"kind": "share_class_conversion",
"after_eur": null,
"delta_eur": null,
"before_eur": null,
"decrease_purpose": null,
"contribution_type": null,
"paid_up_delta_eur": null,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
},
{
"kind": "share_class_creation",
"after_eur": null,
"delta_eur": null,
"before_eur": null,
"decrease_purpose": null,
"contribution_type": null,
"paid_up_delta_eur": null,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
},
{
"kind": "warrant_issuance",
"after_eur": null,
"delta_eur": null,
"before_eur": null,
"decrease_purpose": null,
"contribution_type": "inschrijvingsrechten_uitgifte",
"paid_up_delta_eur": null,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
},
{
"kind": "warrant_issuance",
"after_eur": null,
"delta_eur": null,
"before_eur": null,
"decrease_purpose": null,
"contribution_type": "inschrijvingsrechten_uitgifte",
"paid_up_delta_eur": null,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
},
{
"kind": "warrant_issuance",
"after_eur": null,
"delta_eur": null,
"before_eur": null,
"decrease_purpose": null,
"contribution_type": "inschrijvingsrechten_uitgifte",
"paid_up_delta_eur": null,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
},
{
"kind": "warrant_issuance",
"after_eur": null,
"delta_eur": null,
"before_eur": null,
"decrease_purpose": null,
"contribution_type": "inschrijvingsrechten_uitgifte",
"paid_up_delta_eur": null,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
},
{
"kind": "warrant_issuance",
"after_eur": null,
"delta_eur": null,
"before_eur": null,
"decrease_purpose": null,
"contribution_type": "inschrijvingsrechten_uitgifte",
"paid_up_delta_eur": null,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
},
{
"kind": "warrant_issuance",
"after_eur": null,
"delta_eur": null,
"before_eur": null,
"decrease_purpose": null,
"contribution_type": "inschrijvingsrechten_uitgifte",
"paid_up_delta_eur": null,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
},
{
"kind": "warrant_issuance",
"after_eur": null,
"delta_eur": null,
"before_eur": null,
"decrease_purpose": null,
"contribution_type": "inschrijvingsrechten_uitgifte",
"paid_up_delta_eur": null,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
}
],
"notary": {
"name": "Tim CARNEWAL",
"firm_city": null,
"firm_name": "BERQUIN NOTARISSEN",
"office_city": "Brussel",
"is_associated": true
},
"act_meta": {
"language": "nl",
"pub_date": "2024-07-01",
"filing_date": "2024-06-27",
"act_kind_objet": "Onderwerp akte:"
},
"decision": {
"body": "buitengewone_algemene_vergadering",
"act_date": "2024-06-14",
"unanimous": null,
"under_authorized_capital": false,
"underlying_resolution_date": null
},
"bedrijfsrevisor": {
"waived": false,
"firm_kbo": null,
"firm_name": "Ernst \u0026 Young Bedrijfsrevisoren",
"ibr_number": null,
"mission_type": "apport_nature",
"individual_name": "Brecht Deketele"
},
"subject_company": {
"kbo": "0722.705.230",
"name_full": "AUGUSTINE THERAPEUTICS",
"legal_form": "Naamloze vennootschap",
"is_foreign_registered": false
},
"publication_proxy": {
"kind": "none",
"org_kbo": null,
"org_name": null,
"person_name": null,
"org_rep_person_name": null,
"person_role_at_subject": null
},
"co_filed_documents": [
"expedition",
"plan financier",
"bankattest",
"verslag bedrijfsrevisor"
],
"shareholders_after": [],
"share_classes_after": [
{
"n_shares": 7901926,
"class_name": "Seed Aandelen",
"capital_share_eur": null,
"voting_rights_per_share": 1.0
},
{
"n_shares": 11382879,
"class_name": "Series A Aandelen",
"capital_share_eur": null,
"voting_rights_per_share": 1.0
}
]
}2023
29-11-2023 2 administrateurs nommés
- Christophe Van Vaeck — Persoon belast met het dagelijks bestuur
- P.M.V. — Bestuurder
Détails techniques
{
"events": [
{
"kind": "rep_rotation",
"role": "vaste_vertegenwoordiger",
"person": {
"rrn": null,
"name": "Bart De Taeye",
"address": null,
"birth_date": null,
"profession": null,
"birth_place": null
},
"reason": null,
"subkind": "successor_conditional",
"via_org": null,
"statutory": null,
"compensated": null,
"effective_date": "2023-04-01",
"evidence_quote": "De vennootschap heeft kennis genomen van de beslissing van haar bestuurder P.M.V. om haar vaste vertegenwoordiger, de heer Erik Tambuyzer, te vervangen door de heer Bart De Taeye met ingang vanaf 1 april 2023.",
"decharge_status": null,
"mandate_duration": null,
"rep_rotation_new_rep": "Bart De Taeye",
"rep_rotation_old_rep": "Erik Tambuyzer",
"effective_date_qualifier": null
},
{
"kind": "director_in",
"role": "persoon belast met het dagelijks bestuur",
"person": {
"rrn": null,
"name": "Christophe Van Vaeck",
"address": null,
"birth_date": null,
"profession": null,
"birth_place": null
},
"reason": null,
"subkind": null,
"via_org": {
"kbo": null,
"name": "BIOFINART BV",
"address": null,
"country": null,
"legal_form": "BV"
},
"statutory": null,
"compensated": null,
"effective_date": null,
"evidence_quote": "BIOFINART BV Persoon belast met het dagelijks bestuur Vast vertegenwoordigd door de heer Christophe Van Vaeck",
"decharge_status": null,
"mandate_duration": null,
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": null
},
{
"kind": "director_in",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "P.M.V.",
"address": null,
"birth_date": null,
"profession": null,
"birth_place": null
},
"reason": null,
"subkind": null,
"via_org": null,
"statutory": null,
"compensated": null,
"effective_date": null,
"evidence_quote": "De vennootschap heeft kennis genomen van de beslissing van haar bestuurder P.M.V.",
"decharge_status": null,
"mandate_duration": null,
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": null
}
],
"notary": {
"name": null,
"firm_city": null,
"firm_name": null,
"office_city": "Leuven",
"is_associated": false
},
"act_meta": {
"language": "nl",
"pub_date": "2023-11-29",
"filing_date": "2023-11-20",
"act_kind_objet": "Onderwerp akte:"
},
"decisions": [
{
"body": "enig_aandeelhouder_schriftelijk",
"date": "2023-11-20",
"unanimous": null
}
],
"is_correction": false,
"subject_company": {
"kbo": "0722.705.230",
"name_full": "Augustine Therapeutics",
"legal_form": "NV"
},
"publication_proxy": {
"kind": "none",
"org_kbo": null,
"org_name": null,
"person_name": null,
"org_rep_person_name": null,
"person_role_at_subject": null
},
"co_filed_documents": [],
"corrected_publication_numac": null
}20-09-2023 Transfert du siège social au sein de Leuven
- Gaston Geenslaan 1, 3001 Leuven → Gaston Geenslaan 3-3001 Leuven (Heverlee)
Détails techniques
{
"events": [
{
"kind": "zetel_transfer",
"seat_type": "siege_social",
"new_address": {
"raw": "Gaston Geenslaan 3-3001 Leuven (Heverlee)",
"city": "Leuven",
"region": "vlaams_gewest",
"street": "Gaston Geenslaan",
"country": "BE",
"postcode": "3001",
"box_number": null,
"street_number": "3",
"locality_suffix": "(Heverlee)"
},
"old_address": {
"raw": "Gaston Geenslaan 1, 3001 Leuven",
"city": "Leuven",
"region": "vlaams_gewest",
"street": "Gaston Geenslaan",
"country": "BE",
"postcode": "3001",
"box_number": null,
"street_number": "1",
"locality_suffix": "(Heverlee)"
},
"effective_date": null,
"evidence_quote": "De raad van bestuur keurde de wijziging van het adres van de zetel van de Vennootschap goed van Gaston Geenslaan 1 - 3001 Leuven (Heverlee) naar Gaston Geenslaan 3-3001 Leuven (Heverlee), met onmiddellijke ingang",
"region_changed": false,
"is_statute_change": true,
"nationality_change": false,
"old_address_source": "act_body",
"statute_clause_text": null,
"statute_article_number": null,
"effective_date_qualifier": "immediate",
"statutaire_vs_werkelijke": "statutaire",
"linguistic_region_changed": false,
"court_jurisdiction_changed": false,
"effective_date_is_approximate": false
}
],
"notary": {
"name": null,
"firm_city": null,
"firm_name": null,
"office_city": null,
"is_associated": false
},
"act_meta": {
"language": "nl",
"pub_date": null,
"filing_date": "2023-06-13",
"act_kind_objet": "Onderwerp akte:"
},
"decision": {
"body": "raad_van_bestuur",
"date": "2023-06-13",
"unanimous": null
},
"subject_company": {
"kbo": "0722.705.230",
"name_full": "AUGUSTINE THERAPEUTICS",
"legal_form": "NV"
},
"publication_proxy": {
"kind": "person",
"org_kbo": null,
"org_name": null,
"person_name": "Sylvain Celanire",
"org_rep_person_name": null,
"person_role_at_subject": "gedelgeerd bestuurder"
},
"co_filed_documents": [
"Bijlagen bij het Belgisch Staatsblad",
"Mod DOC 19.01"
]
}03-01-2023 Augmentation de capital de 4.561.521,61 € à 8.235.345,80 €
- €3.673.824,19 → €8.235.345,80
- 3 kapitaalbewegingen in deze akte
Notaire:
Peter VAN MELKEBEKE · BrusselÉtude:
BERQUIN NOTARISSEN
Détails techniques
{
"events": [
{
"kind": "capital_increase",
"after_eur": 8235345.8,
"delta_eur": 4561521.61,
"before_eur": 3673824.19,
"share_emission": {
"agio_eur": null,
"share_form": "no_nominal_value",
"share_class": "Seed",
"n_new_shares": 3508860,
"with_new_shares": true,
"nominal_value_eur": null,
"issue_price_per_share_eur": 1.3
},
"decrease_purpose": null,
"contribution_type": "schuldvordering_inbreng",
"paid_up_delta_eur": null,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
},
{
"kind": "share_class_creation",
"after_eur": null,
"delta_eur": null,
"before_eur": null,
"share_emission": {
"agio_eur": null,
"share_form": null,
"share_class": null,
"n_new_shares": null,
"with_new_shares": false,
"nominal_value_eur": null,
"issue_price_per_share_eur": null
},
"decrease_purpose": null,
"contribution_type": null,
"paid_up_delta_eur": null,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
},
{
"kind": "warrant_issuance",
"after_eur": null,
"delta_eur": null,
"before_eur": null,
"share_emission": {
"agio_eur": null,
"share_form": null,
"share_class": null,
"n_new_shares": null,
"with_new_shares": false,
"nominal_value_eur": null,
"issue_price_per_share_eur": null
},
"decrease_purpose": null,
"contribution_type": null,
"paid_up_delta_eur": null,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
},
{
"kind": "capital_increase",
"after_eur": null,
"delta_eur": null,
"before_eur": null,
"share_emission": {
"agio_eur": null,
"share_form": "no_nominal_value",
"share_class": "Gewone Aandelen",
"n_new_shares": null,
"with_new_shares": true,
"nominal_value_eur": null,
"issue_price_per_share_eur": null
},
"decrease_purpose": null,
"contribution_type": null,
"paid_up_delta_eur": null,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
},
{
"kind": "capital_increase",
"after_eur": null,
"delta_eur": null,
"before_eur": null,
"share_emission": {
"agio_eur": null,
"share_form": "no_nominal_value",
"share_class": "ESOP Gewone Aandelen",
"n_new_shares": null,
"with_new_shares": true,
"nominal_value_eur": null,
"issue_price_per_share_eur": null
},
"decrease_purpose": null,
"contribution_type": null,
"paid_up_delta_eur": null,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
}
],
"notary": {
"name": "Peter VAN MELKEBEKE",
"firm_city": null,
"firm_name": "BERQUIN NOTARISSEN",
"office_city": "Brussel",
"is_associated": true
},
"act_meta": {
"language": "nl",
"pub_date": "2023-01-03",
"filing_date": "2022-12-30",
"act_kind_objet": "Onderwerp akte:"
},
"decision": {
"body": "buitengewone_algemene_vergadering",
"act_date": "2022-12-21",
"unanimous": null,
"under_authorized_capital": false,
"underlying_resolution_date": null
},
"bedrijfsrevisor": {
"waived": false,
"firm_kbo": null,
"firm_name": "BDO Bedrijfsrevisoren BV",
"ibr_number": null,
"mission_type": "apport_nature",
"individual_name": "Veerle CATRY"
},
"subject_company": {
"kbo": "0722.705.230",
"name_full": "AUGUSTINE THERAPEUTICS",
"legal_form": "Naamloze vennootschap",
"is_foreign_registered": false
},
"publication_proxy": {
"kind": "person",
"org_kbo": null,
"org_name": null,
"person_name": "Peter VAN MELKEBEKE",
"org_rep_person_name": null,
"person_role_at_subject": "notaris"
},
"co_filed_documents": [
"uitgifte van het proces-verbaal",
"zes volmachten",
"Aandelenoptieplan",
"het verslag van de raad van bestuur opgesteld in toepassing van de artikelen 7:179, \u00A71, eerste lid en 7:197, \u00A71, eerste lid van het Wetboek van vennootschappen en verenigingen",
"het verslag van de commissaris opgesteld in toepassing van de artikelen 7:179, \u00A71, tweede lid en 7:197, \u00A71, tweede lid van het Wetboek van vennootschappen en verenigingen",
"de verslagen van de raad van bestuur en de commissaris opgesteld in toepassing van artikel 7:155 van het Wetboek van vennootschappen en verenigingen",
"het verslag van de raad van bestuur opgesteld overeenkomstig artikel 7:180, eerste lid van het Wetboek van vennootschappen en verenigingen",
"het verslag van de commissaris opgesteld in toepassing van artikel 7:180, tweede lid van het Wetboek van vennootschappen en verenigingen",
"de geco\u00F6rdineerde tekst van de statuten"
],
"shareholders_after": [],
"share_classes_after": [
{
"n_shares": 461652,
"class_name": "Gewone Aandelen",
"capital_share_eur": null,
"voting_rights_per_share": null
},
{
"n_shares": 7440274,
"class_name": "Seed Aandelen",
"capital_share_eur": null,
"voting_rights_per_share": null
}
]
}2022
30-03-2022 3 administrateurs nommés
- Gert-Jan Audoore — Dagelijks bestuur
- Tine Bassens — Dagelijks bestuur
- Deloitte Legal - Lawyers BV — Dagelijks bestuur
Détails techniques
{
"events": [
{
"kind": "delegation_dagelijks_bestuur_in",
"role": "dagelijks_bestuur",
"person": {
"rrn": null,
"name": "Gert-Jan Audoore",
"address": null,
"birth_date": null,
"profession": null,
"birth_place": null
},
"reason": null,
"subkind": "additional",
"via_org": null,
"statutory": "statutair",
"compensated": null,
"effective_date": "2022-02-10",
"evidence_quote": "De raad van bestuur beslist hierbij volmacht te geven aan Gert-Jan Audoore, Tine Bassens en iedere medewerker van het kantoor Deloitte Legal - Lawyers BV, afzonderlijk handelend, met macht van indeplaatsstelling, voor de opstelling en de ondertekening van het formulier vereist voor de publicatie in ",
"decharge_status": null,
"mandate_duration": {
"kind": "indefinite",
"value": null
},
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": null
},
{
"kind": "delegation_dagelijks_bestuur_in",
"role": "dagelijks_bestuur",
"person": {
"rrn": null,
"name": "Tine Bassens",
"address": null,
"birth_date": null,
"profession": null,
"birth_place": null
},
"reason": null,
"subkind": "additional",
"via_org": null,
"statutory": "statutair",
"compensated": null,
"effective_date": "2022-02-10",
"evidence_quote": "De raad van bestuur beslist hierbij volmacht te geven aan Gert-Jan Audoore, Tine Bassens en iedere medewerker van het kantoor Deloitte Legal - Lawyers BV, afzonderlijk handelend, met macht van indeplaatsstelling, voor de opstelling en de ondertekening van het formulier vereist voor de publicatie in ",
"decharge_status": null,
"mandate_duration": {
"kind": "indefinite",
"value": null
},
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": null
},
{
"kind": "delegation_dagelijks_bestuur_in",
"role": "dagelijks_bestuur",
"person": null,
"reason": null,
"subkind": "additional",
"via_org": {
"kbo": null,
"name": "Deloitte Legal - Lawyers BV",
"address": null,
"country": null,
"legal_form": "BV"
},
"statutory": "statutair",
"compensated": null,
"effective_date": "2022-02-10",
"evidence_quote": "De raad van bestuur beslist hierbij volmacht te geven aan Gert-Jan Audoore, Tine Bassens en iedere medewerker van het kantoor Deloitte Legal - Lawyers BV, afzonderlijk handelend, met macht van indeplaatsstelling, voor de opstelling en de ondertekening van het formulier vereist voor de publicatie in ",
"decharge_status": null,
"mandate_duration": {
"kind": "indefinite",
"value": null
},
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": null
}
],
"notary": {
"name": null,
"firm_city": null,
"firm_name": null,
"office_city": null,
"is_associated": false
},
"act_meta": {
"language": "nl",
"pub_date": null,
"filing_date": "2022-02-17",
"act_kind_objet": "Onderwerp akte:"
},
"decisions": [
{
"body": "enig_aandeelhouder_schriftelijk",
"date": "2022-02-17",
"unanimous": true
}
],
"is_correction": false,
"subject_company": {
"kbo": "0722.705.230",
"name_full": "Augustine Therapeutics",
"legal_form": "NV"
},
"publication_proxy": {
"kind": "person",
"org_kbo": null,
"org_name": null,
"person_name": "Tine Bassens",
"org_rep_person_name": null,
"person_role_at_subject": "Bijzonder gevolmachtigde"
},
"co_filed_documents": [],
"corrected_publication_numac": null
}